Stability-related studies on 17D yellow fever vaccine

Microbes and Infection

Volumn 2, Issue 1, 2000, Pages 33-38

  Perraut, Ronald ^a   Girault, Guy ^a   Moreau, Jean Paul ^a  

^a INSTITUT PASTEUR DE DAKAR   (Senegal)

Author keywords

17D vaccine; Stability; Yellow fever

Indexed keywords

YELLOW FEVER VACCINE;

ARTICLE; DRUG ACTIVITY; DRUG POTENCY; DRUG STABILITY; DRUG STORAGE; DRUG SYNTHESIS; DRUG USE; PRIORITY JOURNAL; YELLOW FEVER; YELLOW FEVER FLAVIVIRUS;

FLAVIVIRUS; RNA VIRUSES; YELLOW FEVER VIRUS;

EID: 0033966113     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)00288-4     Document Type: Article

References (16)

1. . Yellow fever in 1994 and 1995. Wkly. Epidemiol. Rec. 71:1996;313-320.
2. Thonnon J., Fontenille D., Tall A., Diallo M., Renaudineau Y., Baudez B., Raphenon G. Re-emergence of yellow fever in Senegal in 1995. Am. J. Trop. Med. Hyg. 59:1998;108-114.
3. Smith H.H., Penna H.A., Paoliello A. A yellow fever vaccination with culture virus (17D) without immune serum. Am. J. Trop. Med. Hyg. 18:1938;437-468.
4. Peetermans J. Factors affecting the stability of viral vaccines. Dev. Biol. Stand. 87:1996;97-101.
5. . Requirements for Yellow Fever Vaccine, Addendum 1987. WHO Tech. Rep. Ser. 771:1988;208-209.
6. . Yellow Fever Vaccines: thermostability of freeze dried vaccines. Wkly. Epidemiol. Rec. 62:1987;181-183.
7. Saluzzo J.F., Some L., Baudon D., Girault G., Lhuilier M., Kambire P.A., Roux J.F., Digoutte J.P. Use of stabilised yellow fever vaccine 17D at the time of the yellow fever epidemic in Burkina Faso in 1983. Bull. Soc. Path. Exot. 78:1985;536-540.
8. . Requirements for yellow fever vaccine. WHO Tech. Rep. Ser. 594:1976;1-49.
9. . Requirements for yellow fever vaccine. WHO Tech. Rep. Ser. 1:1995;1-16.
10. Sood D.K., Aggarwal R.K., Sharma S.B., Sokhey J., Singh H. Study on the stability of 17D-204 yellow fever vaccine before and after stabilisation. Vaccine. 11:1993;1124-1128.
11. Barme M., Bronnert C. Thermal stability of lyophilized 17D yellow fever virus vaccine. I. Trial of protective substances. J. Biol. Stand. 12:1984;435-442.
12. Barme M., Vacher B., Ryhiner M.L., Chanannier G. Thermostabilization of the lyophilized yellow fever vaccine 17-D. II. Pilot lots prepared under conditions of industrial production. J. Biol. Stand. 15:1987;67-72.
13. DeMadrid A.T., Portefield J.S. A simple micro-culture method for the study of group B arboviruses. Bull. WHO. 40:1969;113-121.
14. Burfoot C., Young P.A., Finter N.B. The thermal stability of a stabilised 17D yellow fever virus vaccine. J. Biol. Stand. 5:1977;173-179.
15. Monath T.P. Stability of yellow fever vaccine. Dev. Biol. Stand. 87:1996;219-225.
16. Lopes O.S., Guimaraes S.S., Carvalho R. Studies on yellow fever vaccines. II- Stability of the reconstituted product. J. Biol. Stand. 16:1988;71-77.